A review on shared clinical and molecular mechanisms between bipolar disorder and frontotemporal dementia

Carregando...
Imagem de Miniatura
Citações na Scopus
21
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
PERGAMON-ELSEVIER SCIENCE LTD
Citação
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, v.93, p.269-283, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Mental disorders are highly prevalent and important causes of medical burden worldwide. Co-occurrence of neurological and psychiatric symptoms are observed among mental disorders, representing a challenge for their differential diagnosis. Psychiatrists and neurologists have faced challenges in diagnosing old adults presenting behavioral changes. This is the case for early frontotemporal dementia (FTD) and bipolar disorder. In its initial stages, FTD is characterized by behavioral or language disturbances in the absence of cognitive symptoms. Consequently, patients with the behavioral subtype of FTD (bv-FTD) can be initially misdiagnosed as having a psychiatric disorder, typically major depression disorder (MDD) or bipolar disorder (BD). Bipolar disorder is associated with a higher risk of dementia in older adults and with cognitive impairment, with a subset of patients presents a neuroprogressive pattern during the disease course. No mendelian mutations were identified in BD, whereas three major genetic causes of FTD have been identified. Clinical similarities between BD and bv-FTD raise the question whether common molecular pathways might explain shared clinical symptoms. Here, we reviewed existing data on clinical and molecular similarities between BD and FTD to propose biological pathways that can be further investigated as common or specific markers of BD and FTD.
Palavras-chave
Bipolar disorder, Frontotemporal dementia, Neuropsychiatric symptoms, Neurodegeneration, Biomarkers
Referências
  1. Aas M, 2014, PSYCHOL MED, V44, P1653, DOI 10.1017/S0033291713002316
  2. Alquezar C, 2016, J PSYCHIATR NEUROSCI, V41, P225, DOI 10.1503/jpn.150131
  3. Alzheimer's Association, 2016, Alzheimers Dement, V12, P459
  4. Anderson AJ, 2000, NEUROBIOL AGING, V21, P511, DOI 10.1016/S0197-4580(00)00126-3
  5. Andreazza AC, 2008, J AFFECT DISORDERS, V111, P135, DOI 10.1016/j.jad.2008.04.013
  6. Anguelova M, 2003, MOL PSYCHIATR, V8, P646, DOI 10.1038/sj.mp.4001336
  7. Aprahamian I, 2014, AM J GERIAT PSYCHIAT, V22, P389, DOI 10.1016/j.jagp.2012.08.013
  8. Arighi A, 2012, J ALZHEIMERS DIS, V31, P447, DOI 10.3233/JAD-2012-120523
  9. Arts B, 2008, PSYCHOL MED, V38, P771, DOI 10.1017/S0033291707001675
  10. Association A. P, 2013, CAUT STAT FOR US DSM
  11. Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043
  12. Baez S., 2017, NEUROPSYCHOLOGIA, DOI [10.1016/j.neuropsychologia, DOI 10.1016/J.NEUROPSYCHOLOGIA]
  13. Bai YM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1143-8
  14. Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016
  15. Balanza-Martinez V, 2010, EUR J PHARMACOL, V626, P87, DOI 10.1016/j.ejphar.2009.10.018
  16. BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x
  17. Bauer Isabelle E, 2017, Mod Trends Pharmacopsychiatry, V31, P10, DOI 10.1159/000470803
  18. Bengesser SA, 2016, CNS NEUROL DISORD-DR, V15, P403, DOI 10.2174/1871527315666160321104613
  19. Berk M, 2011, NEUROSCI BIOBEHAV R, V35, P804, DOI 10.1016/j.neubiorev.2010.10.001
  20. Bernardi L, 2011, J ALZHEIMERS DIS, V24, P415, DOI 10.3233/JAD-2011-101890
  21. Bertoux M, 2012, J NEUROL NEUROSUR PS, V83, P411, DOI 10.1136/jnnp-2011-301849
  22. Beyer JL, 2004, AM J GERIAT PSYCHIAT, V12, P613, DOI 10.1176/appi.ajgp.12.6.613
  23. Blasko I, 2006, DEMENT GERIATR COGN, V21, P9, DOI 10.1159/000089137
  24. Bora E, 2010, BIOL PSYCHIAT, V67, P1097, DOI 10.1016/j.biopsych.2010.01.020
  25. Bora E, 2009, J AFFECT DISORDERS, V113, P1, DOI 10.1016/j.jad.2008.06.009
  26. Borroni B, 2012, J ALZHEIMERS DIS, V31, P243, DOI 10.3233/JAD-2012-120226
  27. Bossu P, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-65
  28. Bourne C, 2013, ACTA PSYCHIAT SCAND, V128, P149, DOI 10.1111/acps.12133
  29. BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809
  30. Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937
  31. Broce I, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002487
  32. Brooks JO, 2009, AM J GERIAT PSYCHIAT, V17, P1022, DOI 10.1097/JGP.0b013e3181ad4d47
  33. Brown NC, 2014, PSYCHIAT RES, V218, P61, DOI 10.1016/j.psychres.2014.04.005
  34. Burdick KE, 2010, ACTA PSYCHIAT SCAND, V122, P499, DOI 10.1111/j.1600-0447.2010.01590.x
  35. Burdick KE, 2015, J CLIN PSYCHIAT, V76, pE342, DOI 10.4088/JCP.14cs09399
  36. Caccamo A, 2015, HUM MOL GENET, V24, P4625, DOI 10.1093/hmg/ddv193
  37. Caccamo A, 2012, AM J PATHOL, V180, P293, DOI 10.1016/j.ajpath.2011.09.022
  38. Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2
  39. Calvo A, 2012, J NEUROL, V259, P2723, DOI 10.1007/s00415-012-6640-1
  40. Cao B, 2016, J PSYCHIATR RES, V73, P102, DOI 10.1016/j.jpsychires.2015.12.012
  41. Cardoso T, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0605-x
  42. Chare L, 2014, J NEUROL NEUROSUR PS, V85, P866, DOI 10.1136/jnnp-2013-306948
  43. Chen DT, 2013, MOL PSYCHIATR, V18, P195, DOI 10.1038/mp.2011.157
  44. Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004
  45. Chiaruttini C, 2009, P NATL ACAD SCI USA, V106, P16481, DOI 10.1073/pnas.0902833106
  46. Cho HJ, 2005, MOL PSYCHIATR, V10, P771, DOI 10.1038/sj.mp.4001663
  47. Choi SSW, 2017, AM J GERIAT PSYCHIAT, V25, P459, DOI 10.1016/j.jagp.2016.10.013
  48. Cichon S, 2011, AM J HUM GENET, V88, P372, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]
  49. Cisse M, 2017, MOL PSYCHIATR, V22, P1562, DOI 10.1038/mp.2016.152
  50. Craddock N, 2006, EUR J HUM GENET, V14, P660, DOI 10.1038/sj.ejhg.5201549
  51. Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017
  52. Cullen B, 2017, ACTA PSYCHIAT SCAND, V135, P593, DOI 10.1111/acps.12733
  53. Cullen B, 2016, J AFFECT DISORDERS, V205, P165, DOI 10.1016/j.jad.2016.06.063
  54. Cunha ABM, 2006, NEUROSCI LETT, V398, P215, DOI 10.1016/j.neulet.2005.12.085
  55. Daglas R, 2015, INT J BIPOLAR DISORD, V3, DOI 10.1186/s40345-015-0024-2
  56. de Oliveira KC, 2012, CELL TISSUE BANK, V13, P315, DOI 10.1007/s10561-011-9258-0
  57. DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011
  58. Delvecchio G, 2019, AUST NZ J PSYCHIAT, V53, P413, DOI 10.1177/0004867418815976
  59. Diniz BS, 2017, AM J GERIAT PSYCHIAT, V25, P357, DOI 10.1016/j.jagp.2016.11.014
  60. Dols Annemiek, 2016, Neuropsychiatr Dis Treat, V12, P2207, DOI 10.2147/NDT.S99229
  61. Dominguez LJ, 2016, CURR OPIN CLIN NUTR, V19, P5, DOI 10.1097/MCO.0000000000000243
  62. Ducharme S, 2015, AM J PSYCHIAT, V172, P827, DOI 10.1176/appi.ajp.2015.14101248
  63. Duffy A, 2014, BRIT J PSYCHIAT, V204, P122, DOI 10.1192/bjp.bp.113.126706
  64. Elderkin-Thompson V, 2004, J INT NEUROPSYCH SOC, V10, P753, DOI 10.1017/S1355617704105067
  65. Elshahawi HH, 2011, J AFFECT DISORDERS, V130, P180, DOI 10.1016/j.jad.2010.10.027
  66. Elvsashagen T, 2013, BIPOLAR DISORD, V15, P855, DOI 10.1111/bdi.12117
  67. Endo R, 2018, BIOL PSYCHIAT, V84, P509, DOI 10.1016/j.biopsych.2018.03.008
  68. Esteras N, 2017, REDOX BIOL, V12, P410, DOI 10.1016/j.redox.2017.03.008
  69. Fernandes BS, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0529-7
  70. Fernandes BS, 2011, J PSYCHIATR RES, V45, P995, DOI 10.1016/j.jpsychires.2011.03.002
  71. Ferrari R, 2014, LANCET NEUROL, V13, P686, DOI 10.1016/S1474-4422(14)70065-1
  72. Ferrier IN, 1999, BRIT J PSYCHIAT, V175, P246, DOI 10.1192/bjp.175.3.246
  73. Floris G, 2012, J NEUROL, V259, P1749, DOI 10.1007/s00415-012-6444-3
  74. Foiani MS, 2018, J NEUROL NEUROSUR PS, V89, P804, DOI 10.1136/jnnp-2017-317260
  75. Forlenza OV, 2016, BIPOLAR DISORD, V18, P63, DOI 10.1111/bdi.12360
  76. Frey BN, 2013, AUST NZ J PSYCHIAT, V47, P321, DOI 10.1177/0004867413478217
  77. Fries GR, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0048-8
  78. Funkiewiez A, 2012, NEUROPSYCHOLOGY, V26, P81, DOI 10.1037/a0025318
  79. Galimberti D, 2008, J NEUROL, V255, P539, DOI 10.1007/s00415-008-0737-6
  80. Galimberti D, 2018, NEUROBIOL AGING, V62, DOI 10.1016/j.neurobiolaging.2017.10.016
  81. Galimberti D, 2015, BIOL PSYCHIAT, V78, P684, DOI 10.1016/j.biopsych.2015.03.028
  82. Galimberti D, 2014, BIPOLAR DISORD, V16, P448, DOI 10.1111/bdi.12169
  83. Galimberti D, 2013, BIOL PSYCHIAT, V74, P384, DOI 10.1016/j.biopsych.2013.01.031
  84. Galimberti D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032164
  85. Galimberti D, 2009, J ALZHEIMERS DIS, V17, P125, DOI 10.3233/JAD-2009-1019
  86. Geser F, 2010, ARCH NEUROL-CHICAGO, V67, P1238, DOI 10.1001/archneurol.2010.254
  87. Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc
  88. Ghidoni Roberta, 2012, Am J Neurodegener Dis, V1, P180
  89. Gigante AD, 2011, INT J NEUROPSYCHOPH, V14, P1075, DOI 10.1017/S146114571000146X
  90. Gildengers AG, 2007, AM J GERIAT PSYCHIAT, V15, P174, DOI 10.1097/JGP.0b013e31802dd367
  91. Goldman JS, 2005, NEUROLOGY, V65, P1817, DOI 10.1212/01.wnl.0000187068.92184.63
  92. Goldsmith DR, 2016, MOL PSYCHIATR, V21, P1696, DOI 10.1038/mp.2016.3
  93. Gorno-Tempini M. L., 2011, CLASSIFICATION PRIMA, DOI 10.1212/WNL.0b013e31821103e6
  94. Goswami U, 2006, BRIT J PSYCHIAT, V188, P366, DOI 10.1192/bjp.188.4.366
  95. Grande I, 2016, LANCET, V387, P1561, DOI 10.1016/S0140-6736(15)00241-X
  96. Gratten J, 2014, NAT NEUROSCI, V17, P782, DOI 10.1038/nn.3708
  97. Green EK, 2013, MOL PSYCHIATR, V18, P1302, DOI 10.1038/mp.2012.142
  98. Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079
  99. Grinberg LT, 2009, NEUROPATH APPL NEURO, V35, P406, DOI [10.1111/j.1365-2990.2008.00997.x, 10.1111/j.1365-2990.2009.00997.x]
  100. Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101
  101. Hajek T, 2014, NEUROPSYCHOPHARMACOL, V39, P2910, DOI 10.1038/npp.2014.148
  102. Hall D, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0567-8
  103. Hanford LC, 2016, BIPOLAR DISORD, V18, P4, DOI 10.1111/bdi.12362
  104. Harrison Paul J, 2018, Mol Psychiatry, DOI 10.1038/s41380-018-0213-3
  105. Hayden EP, 2006, GENES BRAIN BEHAV, V5, P85, DOI 10.1111/j.1601-183X.2005.00138.x
  106. Hetz C, 2017, NAT REV NEUROL, V13, P477, DOI 10.1038/nrneurol.2017.99
  107. Hu WT, 2010, NEUROLOGY, V75, P2079, DOI 10.1212/WNL.0b013e318200d78d
  108. Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508
  109. Ikeda M, 2018, PSYCHIAT CLIN NEUROS, V72, P52, DOI 10.1111/pcn.12611
  110. Jacoby AS, 2016, J AFFECT DISORDERS, V197, P167, DOI 10.1016/j.jad.2016.03.040
  111. Josephs KA, 2016, ACTA NEUROPATHOL, V131, P571, DOI 10.1007/s00401-016-1537-1
  112. Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9
  113. Kapczinski F, 2014, ACTA PSYCHIAT SCAND, V130, P354, DOI 10.1111/acps.12305
  114. Kapczinski F, 2010, MOL PSYCHIATR, V15, P784, DOI 10.1038/mp.2009.112
  115. Kapczinski Flavio, 2008, Expert Rev Neurother, V8, P1101, DOI 10.1586/14737175.8.7.1101
  116. Kato T, 2017, SCHIZOPHR RES, V187, P62, DOI 10.1016/j.schres.2016.10.037
  117. Kerner B, 2014, APPL CLIN GENET, V7, P33, DOI 10.2147/TACG.S39297
  118. Kerr DS, 2016, BIPOLAR DISORD, V18, P71, DOI 10.1111/bdi.12367
  119. Kerstein AH, 2013, J PSYCHIATR PRACT, V19, P498, DOI 10.1097/01.pra.0000438190.04786.16
  120. Kessing LV, 2004, J NEUROL NEUROSUR PS, V75, P1662, DOI 10.1136/jnnp.2003.031773
  121. Kimura T, 2010, J BIOL CHEM, V285, P38692, DOI 10.1074/jbc.M110.136630
  122. Kittel-Schneider S, 2014, J AFFECT DISORDERS, V157, P87, DOI 10.1016/j.jad.2014.01.006
  123. Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27
  124. Kovacs GG, 2013, ACTA NEUROPATHOL, V126, P365, DOI 10.1007/s00401-013-1157-y
  125. Krabbe G, 2017, P NATL ACAD SCI USA, V114, P5029, DOI 10.1073/pnas.1700477114
  126. Lanata SC, 2016, J NEUROL NEUROSUR PS, V87, P501, DOI 10.1136/jnnp-2015-310697
  127. Lanctot Krista L, 2017, Alzheimers Dement (N Y), V3, P440, DOI 10.1016/j.trci.2017.07.001
  128. LASSMANN H, 1995, ACTA NEUROPATHOL, V89, P35, DOI 10.1007/BF00294257
  129. Le Ber I, 2008, BRAIN, V131, P732, DOI 10.1093/brain/awn012
  130. Lee RSC, 2014, J PSYCHIATR RES, V57, P1, DOI 10.1016/j.jpsychires.2014.06.019
  131. Leger GC, 2014, DEMENT GERIATR COGN, V37, P104, DOI 10.1159/000354368
  132. Li M, 2016, NEUROSCI BIOBEHAV R, V68, P218, DOI 10.1016/j.neubiorev.2016.05.031
  133. Lilienbaum Alain, 2013, Int J Biochem Mol Biol, V4, P1
  134. Lin Ashleigh, 2013, Br J Psychiatry Suppl, V54, ps11, DOI 10.1192/bjp.bp.112.119156
  135. Liscic R. M., 2007, ARCH NEUROL-CHICAGO, V64, DOI [10.1001/archneur.64.4.535.535-540.64/4/535, DOI 10.1001/ARCHNEUR.64.4.535.535-540.64/4/535]
  136. Lopes R, 2012, Depress Res Treat, V2012, P275957, DOI 10.1155/2012/275957
  137. Lopez-Gonzalez R, 2016, NEURON, V92, P383, DOI 10.1016/j.neuron.2016.09.015
  138. Lowe J., 2011, NEURODEGENERATION MO, P389
  139. Lowe J., 2015, DEMENTIA GREENFIELDS, P902
  140. MacCabe JH, 2010, BRIT J PSYCHIAT, V196, P109, DOI 10.1192/bjp.bp.108.060368
  141. Mackenzie IRA, 2016, J NEUROCHEM, V138, P54, DOI 10.1111/jnc.13588
  142. Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P87, DOI 10.1007/s00401-011-0838-7
  143. Magalhaes PV, 2012, AUST NZ J PSYCHIAT, V46, P1058, DOI 10.1177/0004867412460593
  144. Maller JJ, 2014, J AFFECT DISORDERS, V169, P118, DOI [10.1016/j.jad.2014.08.016, 10.1010/j.jad.2014.08.016]
  145. Mann-Wrobel MC, 2011, BIPOLAR DISORD, V13, P334, DOI 10.1111/j.1399-5618.2011.00935.x
  146. Martinez A, 2008, J NEUROPATH EXP NEUR, V67, P1122, DOI 10.1097/NEN.0b013e31818e06f3
  147. Martinez-Aran A, 2004, BIPOLAR DISORD, V6, P224, DOI 10.1111/j.1399-5618.2004.00111.x
  148. Salles FHM, 2017, PSYCHOL RES BEHAV MA, V10, P9, DOI 10.2147/PRBM.S104814
  149. Masouy A, 2011, PSYCHOGERIATRICS, V11, P60, DOI 10.1111/j.1479-8301.2010.00348.x
  150. McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z
  151. McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803
  152. Medeiros GC, 2016, REV BRAS PSIQUIATR, V38, P6, DOI 10.1590/1516-4446-2015-1680
  153. Meisler MH, 2013, BIPOLAR DISORD, V15, P326, DOI 10.1111/bdi.12063
  154. Mendez MF, 2007, ARCH NEUROL-CHICAGO, V64, P830, DOI 10.1001/archneur.64.6.830
  155. MILLER BL, 1995, DEMENTIA, V6, P195, DOI 10.1159/000106946
  156. Miller ZA, 2013, J NEUROL NEUROSUR PS, V84, P956, DOI 10.1136/jnnp-2012-304644
  157. Modabbernia A, 2013, BIOL PSYCHIAT, V74, P15, DOI 10.1016/j.biopsych.2013.01.007
  158. Muhleisen TW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4339
  159. Muneer Ather, 2016, Chonnam Med J, V52, P18, DOI 10.4068/cmj.2016.52.1.18
  160. Nascimento C, 2018, NEUROPATH APPL NEURO, V44, P286, DOI 10.1111/nan.12430
  161. Nascimento C, 2016, BRAIN PATHOL, V26, P177, DOI 10.1111/bpa.12296
  162. Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002
  163. Nelson PT, 2011, BRAIN, V134, P1506, DOI 10.1093/brain/awr053
  164. Nery FG, 2016, REV BRAS PSIQUIATR, V38, P197, DOI 10.1590/1516-4446-2015-1801
  165. Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
  166. Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201
  167. Neves-Pereira M, 2002, AM J HUM GENET, V71, P651, DOI 10.1086/342288
  168. Ng ASL, 2017, J MED GENET, V54, P591, DOI 10.1136/jmedgenet-2017-104752
  169. Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252
  170. Notaras M, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.205
  171. Nyatsanza S, 2003, J NEUROL NEUROSUR PS, V74, P1398, DOI 10.1136/jnnp.74.10.1398
  172. Olmos G, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/861231
  173. Orro Germano, 2018, Clin Pract Epidemiol Ment Health, V14, P37, DOI 10.2174/1745017901814010037
  174. Ortega F, 2010, CELL MOL LIFE SCI, V67, P1723, DOI 10.1007/s00018-010-0278-x
  175. Ospina LH, 2018, J AFFECT DISORDERS, V235, P7, DOI 10.1016/j.jad.2018.03.013
  176. Palluzzi F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185797
  177. Panegyres Peter K, 2007, Neuropsychiatr Dis Treat, V3, P637
  178. Passant U, 2005, ALZ DIS ASSOC DIS, V19, pS15, DOI 10.1097/01.wad.0000183084.22562.5a
  179. Passos IC, 2016, ACTA PSYCHIAT SCAND, V134, P91, DOI 10.1111/acps.12581
  180. Pfaffenseller B, 2014, INT J NEUROPSYCHOPH, V17, P1453, DOI 10.1017/S1461145714000443
  181. Picher-Martel V, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0162-6
  182. Rainero I, 2009, DEMENT GERIATR COGN, V27, P543, DOI 10.1159/000225962
  183. Rao S, 2017, J PSYCHIATR RES, V86, P39, DOI 10.1016/j.jpsychires.2016.11.012
  184. Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179
  185. Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010
  186. Rentzos M, 2006, J GERIATR PSYCH NEUR, V19, P114, DOI 10.1177/0891988706286226
  187. Rentzos M, 2006, J NEUROL SCI, V249, P110, DOI 10.1016/j.jns.2006.05.063
  188. Rimol LM, 2010, BIOL PSYCHIAT, V68, P41, DOI 10.1016/j.biopsych.2010.03.036
  189. Rise IV, 2016, NEUROPSYCH DIS TREAT, V12, P1203, DOI 10.2147/NDT.S100843
  190. Rodriguez RD, 2016, J NEUROPATH EXP NEUR, V75, P628, DOI 10.1093/jnen/nlw034
  191. Rohrer JD, 2009, NEUROLOGY, V73, P1451, DOI 10.1212/WNL.0b013e3181bf997a
  192. Rosa AR, 2014, J CLIN PSYCHIAT, V75, pE450, DOI 10.4088/JCP.13m08625
  193. Rotondo A, 2002, AM J PSYCHIAT, V159, P23, DOI 10.1176/appi.ajp.159.1.23
  194. Rubino E, 2017, AMYOTROPH LAT SCL FR, V18, P624, DOI 10.1080/21678421.2017.1339716
  195. Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034
  196. Schoder D, 2010, BRIT J PSYCHIAT, V197, P28, DOI 10.1192/bjp.bp.109.068981
  197. Schouws SNTM, 2016, BIPOLAR DISORD, V18, P148, DOI 10.1111/bdi.12374
  198. Seeley William W., 2017, Cold Spring Harbor Perspectives in Biology, V9, pa023622, DOI 10.1101/cshperspect.a023622
  199. Selznick LA, 1999, J NEUROPATH EXP NEUR, V58, P1020, DOI 10.1097/00005072-199909000-00012
  200. Shahheydari H, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00119
  201. Shi JJ, 2008, AM J MED GENET B, V147B, P1047, DOI 10.1002/ajmg.b.30714
  202. Shioya A, 2015, NEUROPATHOLOGY, V35, P245, DOI 10.1111/neup.12191
  203. Sieben A, 2012, ACTA NEUROPATHOL, V124, P353, DOI 10.1007/s00401-012-1029-x
  204. Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058
  205. Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943
  206. Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013
  207. Snowden JS, 2002, BRIT J PSYCHIAT, V180, P140, DOI 10.1192/bjp.180.2.140
  208. Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355
  209. Soczynska JK, 2009, NEUROTOXICOLOGY, V30, P497, DOI 10.1016/j.neuro.2009.03.004
  210. Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007
  211. Soto C, 2008, ARCH NEUROL-CHICAGO, V65, P184, DOI 10.1001/archneurol.2007.56
  212. Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942
  213. Su JH, 2000, EXP NEUROL, V163, P9, DOI 10.1006/exnr.2000.7340
  214. Svetoni F, 2016, RNA BIOL, V13, P1089, DOI 10.1080/15476286.2016.1211225
  215. Syan SK, 2018, J PSYCHIATR NEUROSCI, V43, P298, DOI 10.1503/jpn.170175
  216. Takada L. T., 2017, HUMAN FRONTAL LOBES
  217. Takada LT, 2016, ALZ DIS ASSOC DIS, V30, P310, DOI 10.1097/WAD.0000000000000153
  218. Takada Leonel T., 2015, Dement. neuropsychol., V9, P219, DOI 10.1590/1980-57642015DN93000003
  219. Tamouza R, 2018, ACTA PSYCHIAT SCAND, V138, P464, DOI 10.1111/acps.12912
  220. Tidemalm D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094097
  221. Torralva T, 2007, NEUROPSYCHOLOGIA, V45, P342, DOI 10.1016/j.neuropsychologia.2006.05.031
  222. Torralva T, 2009, BRAIN, V132, P1299, DOI 10.1093/brain/awp041
  223. Torrent Carla, 2012, J Clin Psychiatry, V73, pe899, DOI 10.4088/JCP.11m07471
  224. Trinh MA, 2012, CELL REP, V1, P676, DOI 10.1016/j.celrep.2012.04.010
  225. Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164
  226. Tseng PT, 2016, J PSYCHIATR RES, V79, P86, DOI 10.1016/j.jpsychires.2016.05.009
  227. Tu KY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002411
  228. Van Rheenen TE, 2017, PSYCHOL MED, V47, P1848, DOI 10.1017/S0033291717000307
  229. Vasconcelos-Moreno MP, 2017, INT J NEUROPSYCHOPH, V20, P445, DOI 10.1093/ijnp/pyx001
  230. Vatsavayi AVV, 2014, INT PSYCHOGERIATR, V26, P987, DOI 10.1017/S1041610214000246
  231. Vavakova M, 2015, OXID MED CELL LONGEV, DOI 10.1155/2015/898393
  232. Velakoulis D, 2009, BRIT J PSYCHIAT, V194, P298, DOI 10.1192/bjp.bp.108.057034
  233. Velakoulis D, 2009, AUST NZ J PSYCHIAT, V43, P739, DOI 10.1080/00048670903001984
  234. Ventriglia M, 2013, BIOMED RES INT, DOI 10.1155/2013/901082
  235. Vieta E, 2013, EUR PSYCHIAT, V28, P21, DOI 10.1016/j.eurpsy.2011.11.007
  236. Vohringer Paul A, 2013, Front Psychiatry, V4, P87, DOI 10.3389/fpsyt.2013.00087
  237. Vrabie M, 2015, ANN GEN PSYCHIATR, V14, DOI 10.1186/s12991-015-0080-0
  238. Waldo ML, 2013, AM J NEURODEGENER DI, V2, P276
  239. Wang AK, 2018, SCHIZOPHRENIA BULL, V44, P75, DOI 10.1093/schbul/sbx035
  240. Wei SM, 2017, CEREB CORTEX, V27, P2175, DOI 10.1093/cercor/bhw072
  241. Wiener CD, 2017, J NEUROIMMUNOL, V307, P33, DOI 10.1016/j.jneuroim.2017.03.003
  242. WILHELMSEN KC, 1994, AM J HUM GENET, V55, P1159
  243. Wood EM, 2013, JAMA NEUROL, V70, P1411, DOI 10.1001/jamaneurol.2013.3956
  244. Woollacott IOC, 2016, J NEUROCHEM, V138, P6, DOI 10.1111/jnc.13654
  245. Woolley JD, 2011, J CLIN PSYCHIAT, V72, P126, DOI 10.4088/JCP.10m06382oli
  246. Woolley JD, 2007, AM J PSYCHIAT, V164, P1811, DOI 10.1176/appi.ajp.2007.07061001
  247. Wray Naomi R., 2012, Frontiers in Genetics, V3, DOI 10.3389/fgene.2012.00118
  248. YASSA R, 1988, J AFFECT DISORDERS, V14, P197, DOI 10.1016/0165-0327(88)90035-3
  249. Young JJ, 2018, THER ADV PSYCHOPHARM, V8, P33, DOI 10.1177/2045125317739818
  250. Zamboni G, 2008, NEUROLOGY, V71, P736, DOI 10.1212/01.wnl.0000324920.96835.95
  251. Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep44811